HRT Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HRT Financial’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56,059	Closed	-$463K	–	3751
2021 Q1	$463K	Buy	56,059 +43,496	+346%	+$459K	﹤0.01%	1851
2020 Q4	$85K	Buy	+12,563	New	+$101K	﹤0.01%	1657
2020 Q1	–	Sell	-107,932	Closed	-$364K	–	1499
2019 Q4	$364K	Buy	107,932 +93,529	+649%	+$223K	0.02%	659
2019 Q3	$30K	Buy	+14,403	New	+$33.6K	﹤0.01%	1323
2019 Q2	–	Sell	-15,350	Closed	-$72K	–	965
2019 Q1	$72K	Buy	+15,350	New	+$40.3K	0.01%	450
2018 Q4	–	Sell	-44,931	Closed	-$197K	–	787
2018 Q3	$197K	Buy	+44,931	New	+$249K	0.03%	335

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial's SRNE Position: Q2 2021 in Review

HRT Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 56,059 shares — an estimated $463K sold.

HRT Financial first reported a position in SRNE in Q3 2018 and held it in 6 quarters. The position peaked at $463K in Q1 2021. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

HRT Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
HRT Financial sold 56,059 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $463K.
HRT Financial first reported a position in Sorrento Therapeutics, Inc. in Q3 2018 and held it in 6 quarters.
HRT Financial's Sorrento Therapeutics, Inc. position peaked at $463K in Q1 2021.
212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.